Cargando…
GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020209/ https://www.ncbi.nlm.nih.gov/pubmed/33882645 http://dx.doi.org/10.3892/or.2021.8016 |
| _version_ | 1783674538627694592 |
|---|---|
| author | Ouyang, Fei Liu, Junling Xia, Meng Lin, Chuyong Wu, Xianqiu Ye, Liping Song, Libing Li, Jun Wang, Jing Guo, Peng He, Mian |
| author_facet | Ouyang, Fei Liu, Junling Xia, Meng Lin, Chuyong Wu, Xianqiu Ye, Liping Song, Libing Li, Jun Wang, Jing Guo, Peng He, Mian |
| author_sort | Ouyang, Fei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8020209 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | D.A. Spandidos |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80202092021-04-10 GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer Ouyang, Fei Liu, Junling Xia, Meng Lin, Chuyong Wu, Xianqiu Ye, Liping Song, Libing Li, Jun Wang, Jing Guo, Peng He, Mian Oncol Rep Corrigendum D.A. Spandidos 2021-05 2021-03-16 /pmc/articles/PMC8020209/ /pubmed/33882645 http://dx.doi.org/10.3892/or.2021.8016 Text en Copyright: © Ouyang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
| spellingShingle | Corrigendum Ouyang, Fei Liu, Junling Xia, Meng Lin, Chuyong Wu, Xianqiu Ye, Liping Song, Libing Li, Jun Wang, Jing Guo, Peng He, Mian GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer |
| title | GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer |
| title_full | GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer |
| title_fullStr | GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer |
| title_full_unstemmed | GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer |
| title_short | GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer |
| title_sort | gins2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020209/ https://www.ncbi.nlm.nih.gov/pubmed/33882645 http://dx.doi.org/10.3892/or.2021.8016 |
| work_keys_str_mv | AT ouyangfei gins2isanovelprognosticbiomarkerandpromotestumorprogressioninearlystagecervicalcancer AT liujunling gins2isanovelprognosticbiomarkerandpromotestumorprogressioninearlystagecervicalcancer AT xiameng gins2isanovelprognosticbiomarkerandpromotestumorprogressioninearlystagecervicalcancer AT linchuyong gins2isanovelprognosticbiomarkerandpromotestumorprogressioninearlystagecervicalcancer AT wuxianqiu gins2isanovelprognosticbiomarkerandpromotestumorprogressioninearlystagecervicalcancer AT yeliping gins2isanovelprognosticbiomarkerandpromotestumorprogressioninearlystagecervicalcancer AT songlibing gins2isanovelprognosticbiomarkerandpromotestumorprogressioninearlystagecervicalcancer AT lijun gins2isanovelprognosticbiomarkerandpromotestumorprogressioninearlystagecervicalcancer AT wangjing gins2isanovelprognosticbiomarkerandpromotestumorprogressioninearlystagecervicalcancer AT guopeng gins2isanovelprognosticbiomarkerandpromotestumorprogressioninearlystagecervicalcancer AT hemian gins2isanovelprognosticbiomarkerandpromotestumorprogressioninearlystagecervicalcancer |